Carregant...

Novel Anticancer Fused Pyrazole Derivatives as EGFR and VEGFR-2 Dual TK Inhibitors

EGFR and VEGFR-2 represent promising targets for cancer treatment as they are very important in tumor development as well as in angiogenesis and metastasis. In this work, 6-amino-4-(2-bromophenyl)-3-methyl-1,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile 1 and (E)-4-(2-Bromobenzylidene)-5-methyl-2,4-...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Chem
Autors principals: Saleh, Nashwa M., El-Gazzar, Marwa G., Aly, Hala M., Othman, Rana A.
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2020
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6993756/
https://ncbi.nlm.nih.gov/pubmed/32039146
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fchem.2019.00917
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!